Another suggested mechanism is a reduced enzymatic activity of LPL, a key enzyme in the removal of triglyceride-rich lipoproteins from plasma, reducing clearance and consequently causing hypertriglyceridaemia [40]. The gene discussed is LPL; the disease is hypertriglyceridemia.